Funding for this research was provided by:
Canadian Institutes of Health Research
Ontario Research Fund Research Excellence (RE-03-020)
Received: 23 July 2018
Accepted: 13 January 2019
First Online: 22 January 2019
Ethics approval and consent to participate
: Blood samples from volunteers were collected with informed consent using a protocol (#05–0221-T) approved by the University Health Network (UHN) Research Ethics Board. Animal studies were approved by UHN Animal Care Committee (AUP # 741.34) and carried out in accordance with the Canadian Council on Animal Care Guidelines.
: Not applicable
: Li Zhang is one of the inventors on 7 DNT cell technology-related patents and serves as a scientific consultant for WYZE BIOTECH Co. Ltd. Other authors declare no conflict of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.